> Genta has entered into an exclusive worldwide licensing agreement with Daiichi Sankyo for the development and commercialization of tesetaxel
(formerly known as DJ-927), a late Phase II oncology therapy. Release
> Millipore has inked a deal with Solabia to market materials used in manufacturing biologics. Release
> Abbott Laboratories' molecular diagnostics unit has joined with Genentech, OSI Pharmaceuticals and Roche to develop a gene test for Tarceva. Release
> Gilead Sciences has submitted a Marketing Authorization Application for marketing approval of aztreonam lysine 75 mg powder for nebuliser solution (aztreonam lysine) in the European Union. Release
> Hovione has purchased 75 percent of Hisyn Pharmaceutical, a Chinese plant that manufactures drug substances. Story
> Novartis will use biomarker detection technology developed by Singulex for its drug development work. Report
> Shareholders have approved the sale of Pharmion to Celgene. Release
This week's most popular story: Pfizer snaps up Serenex in buyout. Report
And Finally... Genetic mutations involving insulin-like growth factor explain why short women live longer. Report